Market Overview

Flu Activity Continues to Rise, Related Prescriptions Up 12% from Last Week; Watch CVS, Walgreen

Related CVS
Morning Market Losers
Benzinga's Top #PreMarket Losers
Rite Aid Halves 1Q Profit as Costs Grow (Fox Business)
Related WAG
Top 4 NYSE Stocks In The Drug Stores Industry With The Highest ROE
Walgreen Co. Or CVS Caremark: Which Would You Rather?
Cavuto: Call for Consistent Press Standards (Fox Business)

Lazard Capital Market's Tom Galluci issued an update on flu activity Monday morning following a note from December 17th which suggested CVS (NYSE: CVS) and Walgreen (NYSE: WAG) could benefit from increased cases of the virus.

The analyst said flu activity was up 12 percent from last week and up a very concerning 94 percent from the same week last year. Prescriptions for cold, cough and/or flu drugs has surged 61 percent from December 2011.

Galluci believes this increase in activity is likely to have a greater effect on hospital volume metrics rather than earnings as a lower-margin business.

Lazard maintains a Buy rating on CVS and a Neutral rating on Walgreen shares.

Posted-In: Analyst Color Analyst Ratings

 

Most Popular

Related Articles (CVS + RAD)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters